New drug applications continue to arrive at the US Food and Drug Administration during the coronavirus crisis, as demonstrated by submissions from Janssen Pharmaceutical Cos., Mallinckrodt PLC, and Aurinia Pharmaceuticals Inc..
Janssen is seeking an indication in relapsing multiple sclerosis for ponesimod, the Johnson & Johnson company announced 18 March...